ResultsNDTV Profit
Cohance Lifesciences Q2 Review: Brokerages Maintain Mixed Views
Negative-32Company event
GreyOak summary
Brokerages like Goldman Sachs retained Buy ratings, while Jefferies and JPMorgan maintained negative or neutral views with mixed target adjustments.
What it affects
- Cohance LifesciencesCOHANCENegative -32
Revenue and profit fell sharply amid margin contraction.Rolling sentiment Negative -54
Source
Read the original at NDTV ProfitMore Cohance Lifesciences news
- Stocks to Watch Today: Tata Steel, Data Patterns, Voltas, Aster DM, GE Shipping, Gland, AnMoneycontrol · Stock view ·
- Cohance Lifesciences Q2 net profit plunges 80%CNBC-TV18 · Results ·
- Cohance Lifesciences site shut after worker dies in accidentBusinessLine · Regulatory ·
- Cohance Life down 3% on plant closure; Thermax falls 14% on earnings missMoneycontrol · Results ·